CERCARE Stroke

Cercare Medical

CERCARE Stroke provides AI-driven stroke lesion identification and quantification together with both traditional blood flow (CBF), blood volume (CBV), mean transit time (MTT), and delay images and perfusion maps of oxygen extraction and metabolism for stroke assessment. The solution works in both CT and MRI settings and can be integrated into clinical workflows in various ways.
Product specifications Information source: Vendor
Last updated: Sept. 25, 2020
General
Product name CERCARE Stroke
Company Cercare Medical
Subspeciality Neuro
Modality CT, MR
Disease targeted Stroke
Key-features stroke lesions identification, stroke lesions quantification, parametric maps
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population All with suspicion of stroke
Input MR PWI, MR DWI, MR T2Flair, CTP
Input format DICOM
Output segmentation overlay, heatmap overlay
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
Certification
CE
Certified, Class IIa , MDD
FDA
No or not yet
Market presence
On market since 11-2019
Distribution channels syngo.via OpenApps, Sectra Amplifier Store, Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers